会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • SELECTIVELY INHIBITING ESTROGEN PRODUCTION AND PROVIDING ESTROGENIC EFFECTS IN THE HUMAN BODY
    • 选择性抑制雌激素在人体内的生产和提供雌激素作用
    • WO2004091545A2
    • 2004-10-28
    • PCT/US2004009129
    • 2004-03-25
    • MORINDA INCPALU AFA KEHAATI
    • PALU AFA KEHAATIWANG MIAN YINGSU CHEN XINGWEST BRETT JUSTINWESTENDORF JOHANNES JOSEPHJENSEN CLAUDE JARAKAESTORY STEPHEN PAUL
    • A61K31/353A61K36/00A61K36/746A61K
    • A61K36/746A61K31/353
    • Implementation is directed to selectively inhibiting estrogen production and providing estrogenic effects in a human body. A dietary supplement includes a processed Morinda citrifolia product that is used to inhibit aromatase or aromatase enzymes that function to convert androgens to estrogens, inhibit receptors from binding with estrogen, and reduce and/or regulate estrogen production, as well as reduce the amount of estrogen produced within the body and regulating such production. The dietary supplement further provides estrogenic effects. The present invention methods and compositions effectively function to treat estrogen-dependent cancers, and particularly inhibit, destroy, and reverse the effects of of estrogen­dependent cancerous tumors through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed Morinda citrifolia products for a safe, pre­determined duration.
    • 实施的目的是选择性地抑制雌激素产生并在人体内提供雌激素作用。 膳食补充剂包括加工的Morinda citrifolia产品,其用于抑制将雄激素转化成雌激素,抑制受体与雌激素结合的芳香酶或芳香酶,以及减少和/或调节雌激素的产生以及减少雌激素的量 在体内生产并调节这种生产。 膳食补充剂进一步提供雌激素作用。 本发明的方法和组合物有效地用于治疗雌激素依赖性癌症,特别是抑制,破坏和逆转雌激素依赖性癌性肿瘤的作用通过引入体内(例如摄取)安全的预定剂量的药物 配制或包含一种或多种加工的Morinda citrifolia产品的组合物用于安全的,预定的持续时间。
    • 5. 发明申请
    • MORINDA CITRIFOLIA LEAF JUICE AND LEAF EXTRACT BASED FORMULATIONS
    • MORINDA CITRIFOLIA LEAF JUICE和LEAF提取物制剂
    • WO2007064521A3
    • 2010-02-18
    • PCT/US2006044949
    • 2006-11-21
    • TAHITIAN NONI INT INCPALU AFA KEHAATIZHOU BING-NANSU CHEN XINGJENSEN CLAUDE JARAKAEWEST BRETT JUSTINSTORY STEPHEN P
    • PALU AFA KEHAATIZHOU BING-NANSU CHEN XINGJENSEN CLAUDE JARAKAEWEST BRETT JUSTINSTORY STEPHEN P
    • A61K36/746A61K36/00
    • A61K36/746
    • A method and composition for inhibiting certain enzymes, where such inhibition results in various health benefits is provided. More particularly, a method and composition using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or Roast Leaf to inhibit the following: HMG-CoA Reductase; Phosphodiesterases (3 and 4) PDE3 and PDE4; 5 -Lipoxygenase (LOX) and 15-LOX; Xanthine Oxidase (XO); Gamma Amino Butyric Acid (GABA) and the growth of the second most common human skin cancer cell line, is provided. Moreover, the foregoing enzymatic inhibitions result in: alleviating pain and inflammation; treating prostate cancers; lowering cholesterol levels; counteracting Diabetes Type II; maintaining the highest possible integrity of cellular interactions in the brain resulting in an undisturbed neural function, (i.e., neuroprotection); ameliorating the effects of asthma and allergies; improving energy; improving insulin secretion; decreasing kidney stone accumulation; alleviating the effects of gout; minimizing convulsions related to epilepsy and other seizure disorders; and providing palliative effects to those addicted to drugs.
    • 用于抑制某些酶的方法和组合物,其中这种抑制作用提供了各种健康益处。 更具体地,使用以下一种或多种的方法和组合:非叶提取物; 诺丽叶汁 和/或烤叶抑制以下:HMG-CoA还原酶; 磷酸二酯酶(3和4)PDE3和PDE4; 5 -Lipoxygenase(LOX)和15-LOX; 黄嘌呤氧化酶(XO); 提供γ-氨基丁酸(GABA)和第二常见的人类皮肤癌细胞系的生长。 此外,上述酶抑制导致:缓解疼痛和炎症; 治疗前列腺癌; 降低胆固醇水平; 抵制糖尿病II型; 维持脑中细胞相互作用的最高可能完整性,导致不受干扰的神经功能(即神经保护); 改善哮喘和过敏的作用; 改善能源; 改善胰岛素分泌; 减少肾结石积累; 减轻痛风的影响; 减少与癫痫和其他癫痫发作相关的惊厥; 并为吸毒成瘾者提供姑息治疗。